EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of Mesangial Cells by Tamsulosin and Pioglitazone Under Hyperglycemic Conditions: An In Vitro and In Vivo Study

Sandra Lizbeth Aguilera-Martínez iD, Martín Humberto Muñoz-Ortega iD, Sandra Luz Martínez-Hernández iD, Jorge Christopher Morones-Gamboa iD, Javier Ventura-Juárez iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sandra Lizbeth Aguilera-Martínez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Basic Sciences Center, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico. Hauptthemen laut MEDLINE: Mesangial Cells, Pioglitazone, Tamsulosin, Hyperglycemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UAA, Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico, Universidad Autónoma de Aguascalientes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a consequence of diabetes mellitus (DM), in which hyperglycemia triggers osmotic and oxidative stress and activates inflammatory pathways. These processes damage kidney cells, with mesangial cells (MCs) undergoing mesangial expansion. Antihyperglycemic drugs prevent the progression of renal disease. Although tamsulosin is not conventionally used for the treatment of DN, its previously reported anti-fibrotic and anti-inflammatory effects in liver and lung injury models suggest that it may exert renoprotective actions like those of pioglitazone, which has also been shown to improve cellular carbohydrate and lipid metabolism. MCs were exposed to 20 mM glucose medium and treated with either 50 nM tamsulosin or 100 nM pioglitazone. Subsequently, cell proliferation, inflammatory markers (NF-κB, IL-1β, IL-17), fibrogenic markers (TGF-β, collagen I), oxidative stress parameters (NRF2, superoxide), and indicators of mesangial activation (α-SMA, rhodamine–phalloidin) were assessed in vitro. Both treatments reduced cellular proliferation and hypertrophy, attenuated the release of reactive oxygen species (ROS), decreased IL-17 and α-SMA expression, and reduced mesangial activation and hypertrophy. In an in vivo model of DN in Wistar rats, both treatments decreased mesangial cell activation and expansion. In conclusion, tamsulosin and pioglitazone exert anti-fibrogenic and anti-inflammatory effects in MCs exposed to HG, thereby limiting mesangial activation and expansion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesangial CellsPioglitazoneTamsulosinHyperglycemiaDiabetic NephropathiesHypoglycemic AgentsAnimalsRatsRats, WistarCell ProliferationOxidative StressMaleReactive Oxygen Species

Stichwörter der Autor:innen

fibrosishigh glucoseinflammationmesangial cellmesangial expansionpioglitazonetamsulosin

Substanzen

PioglitazoneTamsulosinReactive Oxygen SpeciesHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Morphology, Basic Sciences Center, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.
  • Department of Chemistry, Basic Sciences Center, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.
  • Department of Microbiology, Basic Sciences Center, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.

ORCID-Profile: Sandra Lizbeth Aguilera-Martínez, Martín Humberto Muñoz-Ortega, Sandra Luz Martínez-Hernández, Jorge Christopher Morones-Gamboa, Javier Ventura-Juárez

Förderung

  • UAA
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico
  • Universidad Autónoma de Aguascalientes
  • Institute of Science and Technology of the State of Aguascalientes (State Fund for Technological Innovation 2023)

Zitieren

APA

Aguilera-Martínez, S. L., Muñoz-Ortega, M. H., Martínez-Hernández, S. L., Morones-Gamboa, J. C., & Ventura-Juárez, J. (2025). Modulation of Mesangial Cells by Tamsulosin and Pioglitazone Under Hyperglycemic Conditions: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199277

Vancouver

Aguilera-Martínez SL, Muñoz-Ortega MH, Martínez-Hernández SL, Morones-Gamboa JC, Ventura-Juárez J. Modulation of Mesangial Cells by Tamsulosin and Pioglitazone Under Hyperglycemic Conditions: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199277

BibTeX
@article{AguileraMartnez2025,
  author = {Aguilera-Martínez, Sandra Lizbeth and Muñoz-Ortega, Martín Humberto and Martínez-Hernández, Sandra Luz and Morones-Gamboa, Jorge Christopher and Ventura-Juárez, Javier},
  title = {Modulation of Mesangial Cells by Tamsulosin and Pioglitazone Under Hyperglycemic Conditions: An In Vitro and In Vivo Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199277}
}
Kostenlos starten →